Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care

Description

This study's long-term goal is to improve clinical outcomes among smokers living with HIV (SLWH) by providing smoking cessation interventions in HIV clinical care that will increase the chances of quitting smoking, limits costs and burden on staff and reach many smokers living with HIV.

Conditions

Human Immunodeficiency Virus (HIV), Smoking Cessation

Talk to us

Study Overview

On this page

Study Details

Study overview

This study's long-term goal is to improve clinical outcomes among smokers living with HIV (SLWH) by providing smoking cessation interventions in HIV clinical care that will increase the chances of quitting smoking, limits costs and burden on staff and reach many smokers living with HIV.

Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care

Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care

Condition
Human Immunodeficiency Virus (HIV)
Intervention / Treatment

-

Contacts and Locations

New York

New York University School of Global Public Health, New York, New York, United States, 10003

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Status as HIV+
  • * Age 18 or older
  • * Currently smokes ≥ 5 CPD, on average, in past month, carbon monoxide ≥ 7 ppm and positive salivary cotinine
  • * Able to understand the nature of the study and the consenting process
  • * Is engaged in HIV clinical care
  • * Living in larger NYC metropolitan area currently and for the next 6-8 months
  • * Suffer from any medical condition or contraindication precluding use of nicotine replacement therapy
  • * Current use of any tobacco cessation medications (varenicline, NRT patch, gum, lozenge, spray or inhaler, or bupropion, including the use of bupropion/Wellbutrin for depression)
  • * Currently participating in a smoking cessation program
  • * Pregnant or nursing and plans to be in next 6 months
  • * Has a serious or untreated psychiatric illness (bipolar or schizophrenia/schizo-affective disorder)
  • * Has a past 6-month psychiatric hospitalization or psychiatric emergency room visit does not have a functioning mobile phone that can receive text messages

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

New York University,

Study Record Dates

2028-06